Smoldering Myeloma Gets First FDA-Approved Therapy

(MedPage Today) -- The FDA on Thursday approved daratumumab-hyaluronidase (Darzalex Faspro) as the first drug for high-risk smoldering multiple myeloma.
Approval of the subcutaneous daratumumab product was based on positive results from the phase...